Header cover image

Brazilian (BOVESPA) Drug Retail Industry Analysis

UpdatedFeb 22, 2025
DataAggregated Company Financials
Companies4
  • 7D-4.7%
  • 3M-25.5%
  • 1Y-25.9%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has remained flat. As for the longer term, the industry has declined 24% in the last year. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the Brazilian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Feb 2025R$36.0bR$56.7bR$1.4b11.4x25.6x0.6x
Mon, 20 Jan 2025R$39.9bR$56.7bR$1.4b12x28.4x0.7x
Wed, 18 Dec 2024R$43.3bR$56.7bR$1.4b12.1x30.8x0.8x
Fri, 15 Nov 2024R$47.8bR$56.6bR$1.4b13.6x34.3x0.8x
Sun, 13 Oct 2024R$45.2bR$54.8bR$1.3b16.5x36.1x0.8x
Tue, 10 Sep 2024R$50.7bR$54.8bR$1.3b17.2x40.4x0.9x
Thu, 08 Aug 2024R$54.2bR$53.4bR$1.3b16.4x42.4x1x
Sat, 06 Jul 2024R$46.9bR$53.1bR$1.2b28.7x38.8x0.9x
Mon, 03 Jun 2024R$46.3bR$53.1bR$1.2b27.8x38.2x0.9x
Wed, 01 May 2024R$47.4bR$51.4bR$1.2b29.8x40.5x0.9x
Fri, 29 Mar 2024R$50.5bR$51.4bR$1.2b31.9x43.2x1x
Sun, 25 Feb 2024R$48.5bR$49.8bR$1.1b19.7x45.8x1x
Tue, 23 Jan 2024R$49.4bR$49.8bR$1.1b20.1x46.6x1x
Thu, 21 Dec 2023R$54.3bR$49.8bR$1.1b21.2x51.3x1.1x
Sat, 18 Nov 2023R$51.8bR$49.9bR$1.1b20.1x48.9x1x
Mon, 16 Oct 2023R$51.0bR$48.1bR$948.8m20.1x53.7x1.1x
Wed, 13 Sep 2023R$50.5bR$48.1bR$948.8m22.2x53.2x1x
Fri, 11 Aug 2023R$51.0bR$48.0bR$1.0b22.5x49.7x1.1x
Sun, 09 Jul 2023R$53.0bR$46.0bR$1.1b23.4x49.9x1.2x
Tue, 06 Jun 2023R$50.8bR$46.0bR$1.1b20.7x47.9x1.1x
Thu, 04 May 2023R$46.1bR$45.1bR$1.1b18x40.3x1x
Sat, 01 Apr 2023R$43.3bR$43.7bR$1.1b16.6x39.6x1x
Mon, 27 Feb 2023R$41.0bR$41.4bR$1.0b30.3x40.6x1x
Wed, 25 Jan 2023R$44.4bR$41.4bR$1.0b32x43.9x1.1x
Fri, 23 Dec 2022R$42.3bR$41.4bR$1.0b30.6x41.8x1x
Sun, 20 Nov 2022R$42.1bR$41.4bR$1.0b31.2x41.6x1x
Tue, 18 Oct 2022R$41.6bR$39.2bR$1.0b21.2x39.6x1.1x
Thu, 15 Sep 2022R$41.7bR$39.2bR$1.0b19.5x39.7x1.1x
Sat, 13 Aug 2022R$41.3bR$39.1bR$1.0b33.7x39.9x1.1x
Mon, 11 Jul 2022R$36.6bR$37.4bR$945.0m32.2x38.8x1x
Wed, 08 Jun 2022R$39.7bR$37.4bR$945.0m34.6x42.1x1.1x
Fri, 06 May 2022R$37.0bR$37.2bR$944.3m33.4x39.2x1x
Sun, 03 Apr 2022R$46.5bR$36.0bR$997.8m39.9x46.6x1.3x
Tue, 01 Mar 2022R$45.3bR$35.8bR$1.0b33.2x44.6x1.3x
Price to Earnings Ratio

44.6x


Total Market Cap: R$45.3bTotal Earnings: R$1.0bTotal Revenue: R$35.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Drug Retail Industry Price to Earnings3Y Average 42.1x202320242025
Current Industry PE
  • Investors are pessimistic on the Brazilian Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 25.4x which is lower than its 3-year average PE of 42.1x.
  • The industry is trading close to its 3-year average PS ratio of 1.00x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have grown 11% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Brazilian Drug Retail compare with similar industries?

BR Market-1.33%
Consumer Staples-2.58%
Food and Staples Retail-4.34%
Drug Retail-4.69%
Food Distributors0%0
Big Box Super Stores-3.69%
Food Retail-13.42%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News